CTSA K12 Program at UNC
北卡罗来纳大学 CTSA K12 项目
基本信息
- 批准号:10622092
- 负责人:
- 金额:$ 162万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-07-06 至 2028-06-30
- 项目状态:未结题
- 来源:
- 关键词:AccelerationActive LearningAddressCharacteristicsClinicCollaborationsCommunitiesCompanionsDedicationsDisciplineDiseaseEquityFacultyFosteringGenesGrantHealthHealth PolicyInfrastructureK-Series Research Career ProgramsLanguageLeadLeadershipMentored Clinical Scientist Development ProgramMentorsMethodsModelingNorth CarolinaPersonal SatisfactionProductivityProgram DevelopmentResearchScienceScientific Advances and AccomplishmentsScientistServicesSupport SystemSystemTimeTrainingTranslational ResearchTranslationsUnderrepresented PopulationsUniversitiescareercareer developmentcohortempowermentequity, diversity, and inclusionexperiencehealth disparityhealth equityhealth equity promotionlenspeerprogramsrecruitresearch and developmentresilienceskill acquisitionskillstranslational scientist
项目摘要
ABSTRACT
There is an urgent need to develop a new type of scientist, one who is motivated by a need to bring scientific
advances to clinics and communities in an equitable fashion, and to make a long-term impact by contributing to
health policies and research that will promote health equity. This scientist is fluent in the language of team
science and collaboration and recognizes the principles that contribute to scientific translation across disciplines.
This scientist brings an inclusive mindset to how they form and lead their research teams as well as the methods
they use in their research. These characteristics describe a translational scientist. Transforming translational
researchers, historically trained in discipline- and disease-specific approaches, into translational scientists
requires a departure from traditional career development programs. To address this need, the proposed new
CTSA K12 program, the Gene Orringer Advancing Translational Science Career Development Award at the
University of North Carolina at Chapel Hill (UNC-CH), will support nine early-career Scholars with at least 75%
protected time for research and career development activities for up to 3 years. The objectives of the CTSA K12
are to: 1) Recruit junior faculty who are dedicated to accelerating the implementation of biomedical advances
through pursuit of team-based translational science; 2) Increase recruitment efforts of Scholars from
underrepresented groups in biomedical sciences; 3) Provide the necessary infrastructure and protected time for
Scholars to develop skills in the seven Translational Science characteristics through mentored, didactic, and
experiential learning in a format adapted to their specific needs; 4) Empower Scholars with the necessary
leadership, management, well-being, and resilience skills and diversity, equity and inclusion training needed to
lead diverse and inclusive research programs through didactic and experiential trainings, career coaching and
career development experiences; 5) Prepare Scholars to identify and address health disparities through focused
trainings and applied experiences in systems science, health equity and community/stakeholder engagement;
6) Optimize mentoring committee-Scholar relationships by requiring mentor and mentee training based on
evidence-informed mentoring practices and active assessment of mentoring relationships; 7) Develop Scholars
into effective mentors for mentees from diverse backgrounds through didactic training and mentor skills
development; 8) Integrate Scholars into programs and services of the current and planned local UM1 and
companion grants and the CTSA Consortium. Our approach is to foster Scholars in embracing a translational
science mindset using a “cohort training model” that we have leveraged successfully at UNC, immersing
Scholars in the frameworks, methods and operational principles used by their peers in other disciplines while
creating a support system that encourages retention in science. CTSA K12 Scholars will mature into productive
and independent translational scientists that will accelerate research findings into health and societal benefits by
approaching their science and leadership from a lens of equity.
抽象的
迫切需要开发一种新型的科学家,这是一个受到科学的需要的动力
以公平的方式进步诊所和社区,并通过贡献
卫生政策和研究将促进健康公平。这位科学家能说得很流利
科学与协作,并认识到有助于跨学科的科学翻译的原则。
这位科学家为他们如何形成和领导研究团队以及方法带来了包容性的心态
他们在研究中使用。这些特征描述了一位翻译科学家。转变翻译
从历史上接受纪律和疾病特定方法的研究人员进入转化科学家
需要偏离传统的职业发展计划。为了满足这一需求,拟议的新需求
CTSA K12计划,Gene Orringer推进了翻译科学职业发展奖
北卡罗来纳大学教堂山(UNC-CH),将支持至少75%的九名早期学者学者
为研究和职业发展活动的保护时间长达3年。 CTSA K12的对象
是:1)致力于加速生物医学进步的招聘初级教师
通过追求基于团队的转化科学; 2)增加学者的招聘工作
生物医学科学中代表性不足的群体; 3)提供必要的基础设施和受保护的时间
通过指导,教学和
以适合其特定需求的格式学习的经验; 4)授权学者有必要
领导,管理,福祉以及韧性技巧以及多样性,公平和包容培训需要
通过教学和经验丰富的培训,职业教练和
职业发展经验; 5)准备学者通过重点识别和解决健康分配
系统科学,卫生公平和社区/利益相关者参与方面的培训和应用经验;
6)通过需要基于心理和心理培训来优化心理委员会的关系
循证的心理实践和对心理关系的积极评估; 7)发展学者
通过教学培训和导师技能,成为来自潜水员背景的导师的有效导师
发展; 8)将学者整合到当前和计划的本地UM1的计划和服务中
伴侣赠款和CTSA财团。我们的方法是培养学者拥抱翻译
科学的心态使用我们成功地在UNC上利用的“队列培训模型”,沉浸
框架,方法和操作原理中的学者在其他学科中使用
创建一个鼓励在科学中保留的支持系统。 CTSA K12学者将成熟成生产力
独立翻译科学家将通过研究结果加速研究结果
从公平镜头接近他们的科学和领导才能。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Michelle Hernandez其他文献
Michelle Hernandez的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Michelle Hernandez', 18)}}的其他基金
The Role of Interlocutor Behavior on Code Switching Patterns in Bilingual Children with and without Developmental Language Disorders
对话者行为对患有或不患有发展性语言障碍的双语儿童的语码转换模式的作用
- 批准号:
10824125 - 财政年份:2023
- 资助金额:
$ 162万 - 项目类别:
IL-1 receptor blockade as a novel treatment for exacerbation of allergic airway responses in humans
IL-1受体阻断作为人类过敏性气道反应恶化的新型治疗方法
- 批准号:
10206234 - 财政年份:2017
- 资助金额:
$ 162万 - 项目类别:
IL-1 receptor blockade as a novel treatment for exacerbation of allergic airway responses in humans
IL-1受体阻断作为人类过敏性气道反应恶化的新型治疗方法
- 批准号:
10013283 - 财政年份:2017
- 资助金额:
$ 162万 - 项目类别:
IL-1 receptor blockade as a novel treatment for exacerbation of allergic airway responses in humans
IL-1受体阻断作为人类过敏性气道反应恶化的新型治疗方法
- 批准号:
9380678 - 财政年份:2017
- 资助金额:
$ 162万 - 项目类别:
Down-regulation of oxidant-induced airway inflammation though modulation of NRF2
通过调节 NRF2 下调氧化剂诱导的气道炎症
- 批准号:
8353647 - 财政年份:2012
- 资助金额:
$ 162万 - 项目类别:
Down-regulation of oxidant-induced airway inflammation though modulation of NRF2
通过调节 NRF2 下调氧化剂诱导的气道炎症
- 批准号:
8708080 - 财政年份:2012
- 资助金额:
$ 162万 - 项目类别:
Down-regulation of oxidant-induced airway inflammation though modulation of NRF2
通过调节 NRF2 下调氧化剂诱导的气道炎症
- 批准号:
8531934 - 财政年份:2012
- 资助金额:
$ 162万 - 项目类别:
相似国自然基金
企业领导者积极心理优势的识别、效应及机制:基于追随者视角的研究
- 批准号:71872117
- 批准年份:2018
- 资助金额:48.0 万元
- 项目类别:面上项目
积极背景刺激影响学习记忆的认知神经机制
- 批准号:31470980
- 批准年份:2014
- 资助金额:80.0 万元
- 项目类别:面上项目
大规模垃圾邮件过滤中的集成化SVM增量学习机制研究
- 批准号:60970081
- 批准年份:2009
- 资助金额:31.0 万元
- 项目类别:面上项目
相似海外基金
The contribution of air pollution to racial and ethnic disparities in Alzheimer’s disease and related dementias: An application of causal inference methods
空气污染对阿尔茨海默病和相关痴呆症的种族和民族差异的影响:因果推理方法的应用
- 批准号:
10642607 - 财政年份:2023
- 资助金额:
$ 162万 - 项目类别:
Combining sources of information to improve HIV pre-exposure prophylaxis
结合信息来源改善艾滋病毒暴露前预防
- 批准号:
10700193 - 财政年份:2023
- 资助金额:
$ 162万 - 项目类别:
Diversity in a Dish: Pluripotent Stem Cells in Genetic Analysis and Disease Modeling
培养皿中的多样性:遗传分析和疾病建模中的多能干细胞
- 批准号:
10608751 - 财政年份:2023
- 资助金额:
$ 162万 - 项目类别: